Mark Ethan, Goldsman David, Keskinocak Pinar, Sokol Joel
H. Milton Stewart School of Industrial and Systems Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
Transpl Infect Dis. 2019 Dec;21(6):e13181. doi: 10.1111/tid.13181. Epub 2019 Oct 9.
Over 19% of deceased organ donors are labeled increased risk for disease transmission (IRD) for viral blood-borne disease transmission. Many potential organ recipients need to decide between accepting an IRD organ offer and waiting for a non-IRD organ.
Using machine learning and simulation, we built transplant and waitlist survival models and compared the survival for patients accepting IRD organ offers or waiting for non-IRD organs for the heart, liver, and lung. The simulation consisted of generating 20 000 different scenarios of a recipient either receiving an IRD organ or waiting and receiving a non-IRD organ.
In the simulations, the 5-year survival probabilities of heart, liver, and lung recipients who accepted IRD organ offers increased on average by 10.2%, 12.7%, and 7.2%, respectively, compared with receiving a non-IRD organ after average wait times (190, 228, and 223 days, respectively). When the estimated waitlist time was at least 5 days for the liver, and 1 day for the heart and lung, 50% or more of the simulations resulted in a higher chance of 5-year survival when the patient received an IRD organ versus when the patient remained on the waitlist. We also developed a simple equation to estimate the benefits, in terms of 5-year survival probabilities, of receiving an IRD organ versus waiting for a non-IRD organ, for a particular set of recipient/donor characteristics.
For all three organs, the majority of patients are predicted to have higher 5-year survival accepting an IRD organ offer compared with waiting for a non-IRD organ.
超过19%的已故器官捐献者被标记为病毒血源性疾病传播的疾病传播风险增加(IRD)。许多潜在的器官接受者需要在接受IRD器官供体和等待非IRD器官之间做出决定。
我们使用机器学习和模拟方法,建立了移植和等待名单生存模型,并比较了接受IRD器官供体或等待心脏、肝脏和肺的非IRD器官的患者的生存率。模拟包括生成20000种不同的情况,即接受者接受IRD器官或等待并接受非IRD器官。
在模拟中,接受IRD器官供体的心脏、肝脏和肺接受者的5年生存概率,与平均等待时间(分别为190天、228天和223天)后接受非IRD器官相比,平均分别提高了10.2%、12.7%和7.2%。当肝脏的估计等待名单时间至少为5天,心脏和肺为1天时,50%或更多的模拟结果显示,患者接受IRD器官时5年生存的机会高于留在等待名单上。我们还开发了一个简单的方程,用于根据特定的受体/供体特征,估计接受IRD器官与等待非IRD器官相比在5年生存概率方面的益处。
对于所有这三种器官,预计大多数患者接受IRD器官供体的5年生存率高于等待非IRD器官。